Drugs / Autologous endothelial progenitor CD133 stem cell from the bone marrow
Autologous endothelial progenitor CD133 stem cell from the bone marrow
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02287974 | Sep 2011 → Jul 2018 | limb ischemia | Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous endothelial progenitor CD133 stem cell from the bone marrow | “Autologous endothelial progenitor CD133 stem cell from the bone marrow in an unique infusion of 2 - 7 millions of CD133 cells” NCT02287974 ↗ |
| Modality | Cell therapy | “autologous progenitor endothelial CD133 cells from the bone marrow” NCT02287974 ↗ |
| Route | Other | “intra-arterial infusion of stem cells” NCT02287974 ↗ |